ChromaDex, Inc.
Clinical trials sponsored by ChromaDex, Inc., explained in plain language.
Supplements and ingredients company known for NAD+ precursor Niagen.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a vitamin B3 boost erase wrinkles? trial tests topical NAD+ booster Results expected Dec 2026 (estimated)
-
Could a vitamin B3 boost erase wrinkles? trial tests topical NAD+ booster
Symptom relief Recruiting nowThis trial tests whether a topical form of niacinamide riboside (NR), a vitamin B3 derivative that boosts NAD+ in cells, can reduce signs of facial aging. Women aged 30-60 with fine lines and wrinkles will apply one of three doses of NR or a placebo gel to their face twice daily …
Sponsor: ChromaDex, Inc. • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Can an injection boost energy? new study tests niagen plus for fatigue
Symptom relief Recruiting nowThis study is testing the safety of Niagen Plus, an injectable form of vitamin B3, in 40 healthy adults who feel tired. Participants will receive injections under the skin or into muscle over 100 days. Researchers will monitor side effects and measure changes in NAD+ levels, fati…
Phase 1 • Sponsor: ChromaDex, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC